Global Assisted Reproductive Technology Market Set to Reach $50.24 Billion by 2034
The global Assisted Reproductive Technology (ART) market is poised for significant growth, with projections indicating a valuation of nearly USD 50.24 billion by 2034, a substantial increase from USD 28.66 billion in 2024. The market is expected to register a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period from 2025 to 2034, according to a new report from Polaris Market Research.
ART encompasses a range of medical procedures designed to assist individuals and couples facing infertility challenges. These complex treatments include In Vitro Fertilization (IVF), which has emerged as the most widely adopted method. IVF involves the fertilization of eggs in a lab, followed by the transfer of embryos into the uterus, and is often aided by tools such as IVF success estimators.
Key drivers of market growth include rising infertility rates attributed to factors such as delayed childbearing and lifestyle changes, including poor diets and increased environmental exposure. Technological advancements in ART, including Intracytoplasmic Sperm Injection (ICSI) and Preimplantation Genetic Testing (PGT), have also enhanced success rates.
Fertility clinics are currently the largest segment in the market due to their specialized services and state-of-the-art infrastructure. North America and Europe remain dominant regions for ART, fueled by robust healthcare systems and public awareness. However, the Asia-Pacific region is emerging as a growth hotspot, driven by escalating medical tourism and rising disposable incomes.
The ART marketplace is competitive, with leading companies such as Boston IVF, CooperSurgical, and Merck KGaA striving for market share. As ART continues to evolve and gain acceptance, stakeholders are expected to pursue innovative solutions to meet growing demand.
For more insights, visit Polaris Market Research.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.]
